Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack has significant risks: 1 interaction(s) to avoid and 1 critical warning(s). Review carefully before proceeding.
1 combination(s) marked "avoid": Ezetimibe + Nandrolone. Review these interactions carefully.

Cumulative Organ Load

Heart
moderate
Gonads
moderate
Blood Vessels
low
Liver
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Ezetimibe, Nandrolone). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds disrupt lipids (Ezetimibe, Nandrolone). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Ezetimibe, Nandrolone). Monitor accordingly.
!
Ezetimibe + Nandrolone
Avoid

Both Ezetimibe and Nandrolone carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Mechanism-based 75% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.